I graduated in 2017 from the University of Liège (Belgium) with a Master's degree in Biomedical and Pharmaceutical Sciences with a research focus. Afterwards, I realized a PhD thesis within the Medicinal Chemistry and Pharmacognosy laboratories at ULiège. This FRIA thesis, co-directed by Dr. P. Francotte and Pr. M. Frédérich, aimed at the pharmacomodulation of natural polyphenolic substances, mainly ellagic acid, in order to develop new drug candidates against malaria. Having defended my thesis in December 2021, I joined the I2BM team in the Department of Molecular Chemistry at the University of Grenoble-Alpes (France) in March 2022 to work with Dr. T. Lavergne on the development of a DNA-encoded cyclopeptoids library to target G-quadruplex structures.
In 2023, I moved to the University of California San Francisco to work within Prof. Renslo's lab on development of new antivirals as part of the AVIDD initiative, as well as the synthesis of a large library of ligands targeting potassium-leaking channels (K2P), in collaboration with Prof. Minor's Lab at UCSF.
In 2025, I started a postdoc position at ICMR and ESCAPE, University Reims Champagne-Ardenne, in collaboration with Santé publique France, the National Reference Center for Toxoplasmosis, and CHU Reims. My research focused on African plants and terpenic compounds to discover metabolites active against Toxoplasma gondii and Cryptosporidium.
I graduated in 2017 from the University of Liège (Belgium) with a Master's degree in Biomedical and Pharmaceutical Sciences with a research focus. Afterwards, I realized a PhD thesis within the Medicinal Chemistry and Pharmacognosy laboratories at ULiège. This FRIA thesis, co-directed by Dr. P. Francotte and Pr. M. Frédérich, aimed at the pharmacomodulation of natural polyphenolic substances, mainly ellagic acid, in order to develop new drug candidates against malaria. Having defended my thesis in December 2021, I joined the I2BM team in the Department of Molecular Chemistry at the University of Grenoble-Alpes (France) in March 2022 to work with Dr. T. Lavergne on the development of a DNA-encoded cyclopeptoids library to target G-quadruplex structures.
In 2023, I moved to the University of California San Francisco to work within Prof. Renslo's lab on development of new antivirals as part of the AVIDD initiative, as well as the synthesis of a large library of ligands targeting potassium-leaking channels (K2P), in collaboration with Prof. Minor's Lab at UCSF.
In 2025, I started a postdoc position at ICMR and ESCAPE, University Reims Champagne-Ardenne, in collaboration with Santé publique France, the National Reference Center for Toxoplasmosis, and CHU Reims. My research focused on African plants and terpenic compounds to discover metabolites active against Toxoplasma gondii and Cryptosporidium.